tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

187 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -1.95, suggesting Keros Therapeutics is a Buy.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 56.03, while Keros Therapeutics’s (KROS) share price is $50.87, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 57.95, while Keros Therapeutics’s (KROS) share price is $50.87, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

May 21, 2024, 06:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.69
50.24
51.26
52.81
53.83
55.38
56.40
Fibonacci
50.24
51.22
51.83
52.81
53.79
54.40
55.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

May 21, 2024, 06:20 PM
Period
Simple
Exponential
MA5
53.17Sell
53.29Sell
MA10
54.86Sell
54.45Sell
MA20
56.14Sell
56.03Sell
MA50
60.50Sell
57.95Sell
MA100
58.37Sell
55.65Sell
MA200
45.50Buy
48.46Buy
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 54.45, while Keros Therapeutics’s (KROS) share price is $50.87, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 55.65, while Keros Therapeutics’s (KROS) share price is $50.87, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $50.87 and Keros Therapeutics’s (KROS) 50-day simple moving average is 60.50, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $50.87 and Keros Therapeutics’s (KROS) 100-day simple moving average is 58.37, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $50.87 and Keros Therapeutics’s (KROS) 200-day simple moving average is 45.50, creating a Buy signal.

Keros Therapeutics (KROS) Technical Indicators

May 21, 2024, 06:20 PM
Name
Value
Implied Action
RSI (14)
36.65
Neutral
STOCH (9,6)
10.65
Buy
STOCHRSI (14)
9.73
Buy
MACD (12,26)
-1.95
Buy
ADX (14)
26.81
Neutral
Williams %R
-90.88
Buy
CCI (14)
-133.85
Buy
ATR (14)
2.92
-
Ultimate Oscillator
35.89
Neutral
ROC
-7.13
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 36.65, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 26.81, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -133.85, creating a Buy signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -7.13, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 36.65, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is -1.95, which suggests KROS is a Buy.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 53.17, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 56.14, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 60.50, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 45.50, which suggests KROS is a Buy.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -90.88, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -133.85, which suggests KROS is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis